Anssi Solismaa

517 total citations · 1 hit paper
15 papers, 131 citations indexed

About

Anssi Solismaa is a scholar working on Psychiatry and Mental health, Surgery and Physiology. According to data from OpenAlex, Anssi Solismaa has authored 15 papers receiving a total of 131 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Surgery and 4 papers in Physiology. Recurrent topics in Anssi Solismaa's work include Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Regulation of Appetite and Obesity (3 papers). Anssi Solismaa is often cited by papers focused on Schizophrenia research and treatment (5 papers), Bipolar Disorder and Treatment (4 papers) and Regulation of Appetite and Obesity (3 papers). Anssi Solismaa collaborates with scholars based in Finland, Sweden and Norway. Anssi Solismaa's co-authors include Olli Kampman, Niko Seppälä, Esa Leìnonen, Heidi Taipale, Jari Tiihonen, Merja Viikki, Antti O. Tanskanen, Markku Lähteenvuo, Ellenor Mittendorfer‐Rutz and Terho Lehtimäki and has published in prestigious journals such as Psychiatry Research, JAMA Psychiatry and Journal of Psychopharmacology.

In The Last Decade

Anssi Solismaa

12 papers receiving 131 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder

2024 42 citations Markku Lähteenvuo, Jari Tiihonen et al. JAMA Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anssi Solismaa Finland	7	58	43	30	24	17	15	131
J. Viguera Romero Spain	9	138 2.4×	23 0.5×	8 0.3×	38 1.6×	26 1.5×	28	232
Vasiliki Mamakou Greece	5	58 1.0×	47 1.1×	6 0.2×	33 1.4×	26 1.5×	7	148
Donna Lawson United States	5	16 0.3×	41 1.0×	13 0.4×	18 0.8×	10 0.6×	5	80
Gideon Allick Netherlands	8	53 0.9×	63 1.5×	17 0.6×	116 4.8×	62 3.6×	8	240
Christine E. Richards United States	6	49 0.8×	199 4.6×	17 0.6×	24 1.0×	54 3.2×	6	292
Н. П. Гарганеева Russia	6	33 0.6×	9 0.2×	16 0.5×	19 0.8×	19 1.1×	41	113
Maria Urbano Italy	9	63 1.1×	8 0.2×	24 0.8×	52 2.2×	28 1.6×	16	166
Zahra Mahmood Pakistan	4	13 0.2×	15 0.3×	10 0.3×	48 2.0×	43 2.5×	6	128
Heather Snyder United States	7	21 0.4×	28 0.7×	20 0.7×	10 0.4×	20 1.2×	15	216
Ante Tvrdeić Croatia	9	13 0.2×	15 0.3×	15 0.5×	32 1.3×	27 1.6×	22	168

Countries citing papers authored by Anssi Solismaa

Since Specialization

Citations

This map shows the geographic impact of Anssi Solismaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anssi Solismaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anssi Solismaa more than expected).

Fields of papers citing papers by Anssi Solismaa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anssi Solismaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anssi Solismaa. The network helps show where Anssi Solismaa may publish in the future.

Co-authorship network of co-authors of Anssi Solismaa

This figure shows the co-authorship network connecting the top 25 collaborators of Anssi Solismaa. A scholar is included among the top collaborators of Anssi Solismaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anssi Solismaa. Anssi Solismaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Solismaa, Anssi, Ari Ahola‐Olli, Espen Molden, et al.. (2025). Meta-analyses of clozapine, norclozapine levels and their ratio across three genome wide association studies. Translational Psychiatry. 15(1). 431–431.

Solismaa, Anssi, Leo-Pekka Lyytikäinen, Nina Mononen, et al.. (2024). Leptin and leptin receptor gene polymorphisms and depression treatment response. Acta Neuropsychiatrica. 37. e38–e38.

Lähteenvuo, Markku, Jari Tiihonen, Anssi Solismaa, et al.. (2024). Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. JAMA Psychiatry. 82(1). 94–94. 42 indexed citations breakdown →

Solismaa, Anssi, Leo‐Pekka Lyytikäinen, Merja Viikki, et al.. (2024). Polymorphisms in ERBB4 and TACR1 associated with dry mouth in clozapine-treated patients. Acta Neuropsychiatrica. 36(4). 218–223.

Solismaa, Anssi, et al.. (2023). Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports. Journal of Psychopharmacology. 37(2). 229–233. 2 indexed citations

Solismaa, Anssi, Leo‐Pekka Lyytikäinen, Nina Mononen, et al.. (2023). Genetic risk scores associated with temperament clusters in Finnish depression patients. Acta Neuropsychiatrica. 36(1). 51–59. 1 indexed citations

Schoretsanitis, Georgios, Robert L. Smith, Espen Molden, et al.. (2021). European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed. Journal of Clinical Psychopharmacology. 41(2). 140–147. 19 indexed citations

Solismaa, Anssi, Niko Seppälä, Mari Hämäläinen, et al.. (2021). Glucagon-like peptide-1 serum levels are associated with weight gain in patients treated with clozapine. Psychiatry Research. 306. 114227–114227. 4 indexed citations

Solismaa, Anssi, et al.. (2020). Clozapine-Related Diarrhea and Colitis. Journal of Clinical Psychopharmacology. 40(3). 293–296. 4 indexed citations

10.

Solismaa, Anssi, Olli Kampman, Leo‐Pekka Lyytikäinen, et al.. (2018). Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine. Journal of Clinical Psychopharmacology. 38(3). 193–199. 5 indexed citations

11.

Solismaa, Anssi, Olli Kampman, Leo‐Pekka Lyytikäinen, et al.. (2017). Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients. European Neuropsychopharmacology. 27(5). 442–449. 12 indexed citations

12.

Kampman, Olli, Anssi Solismaa, Leo‐Pekka Lyytikäinen, et al.. (2016). Association Study of Arcuate Nucleus Neuropeptide Y Neuron Receptor Gene Variation And Serum Npy Levels in Clozapine Treated Patients With Schizophrenia. European Psychiatry. 40. 13–19. 8 indexed citations

13.

Kampman, Olli, Anssi Solismaa, Leo‐Pekka Lyytikäinen, et al.. (2016). INSIG2Polymorphism and Weight Gain, Dyslipidemia and Serum Adiponectin in Finnish Patients with Schizophrenia Treated with Clozapine. Pharmacogenomics. 17(18). 1987–1997. 7 indexed citations

14.

Solismaa, Anssi, Olli Kampman, Niko Seppälä, et al.. (2014). Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment. Human Psychopharmacology Clinical and Experimental. 29(4). 336–341. 16 indexed citations

15.

Seppälä, Niko, et al.. (2014). Factors associated with subjective side-effects during clozapine treatment. Nordic Journal of Psychiatry. 69(3). 161–166. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact